Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients (DEX-TBI)

NCT06620393 is registered in ClinicalTrials.gov with Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal as lead sponsor.

NCT NCT06620393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06620393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients (DEX-TBI)
Lead sponsor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
October 1, 2024
Completion date
December 1, 2026
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

agitation,psychomotor, traumatic brain injury